Modified version of the Gore TAG Thoracic Endoprosthesis receives FDA approval


Gore announced at the International Congress of Endovascular Interventions, in Arizona, US, that it has received approval from the FDA to market a modified version of the Gore TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms.

The improved delivery catheter enhances the previous version of the endoprosthesis by adding a soft flexible tip to the leading end of the delivery system. The soft tip improves flexibility at the wire/catheter interface to facilitate tracking through challenging aortic anatomy. The hub component has also been modified to improve ease of use and durability.

The GoreTAG Thoracic Endoprosthesis internally relines the thoracic aorta and isolates the diseased segment from blood circulation. The endoprosthesis is comprised of an ePTFE graft with an outer self-expanding nitinol support structure to combine both device flexibility and material durability. The device is inserted by a catheter delivery technique through a small incision in the patient’s groin.